异动解读 | AVR首次公开募股后盘中暴跌12.33%,募资增股致短期供给压力

异动解读
14 Dec 2024

心脏瓣膜公司Anteris Technologies Global (AVR) 在纳斯达克上市首日当日暴跌12.33%,引发市场广泛关注。

AVR当日在纳斯达克进行首次公开募股,发行价为每股6美元,共募集约8,900万美元资金。但开盘后股价即呈现大跌,盘中一度下探至5.26美元。

市场分析认为,AVR首次公开募股增发新股导致股票供给激增,短期内形成供给压力拖累股价下跌,同时或有投机资金涌入、出货操作亦加剧了股价震荡。投资者对未来发展前景存在分歧,市场情绪转差致股价重挫。预计供需矛盾在未来将得到缓解,股价震荡将趋于平稳。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10